In the year 1546, the first official pharmacopoeia appeared in Germany and the profession of pharmaceuticals is stated to have begun in the year 1617 in the town of London with the formation of Society of Apothecaries. Since then the pharmaceutical Industry has come a long way due to the unification of fields of chemistry and physiology led to a better understanding of the drug creating process.
Pharmaceuticals are substances which are used in the diagnosis, treatment, prevention of diseases and for restoring, correcting or modifying organic functions. Pharmaceuticals are generally classified by the chemical group, the way they work in the body (the pharmacological effect) and by the therapeutic use. The pharmaceuticals industry is aimed at discovery, development and production, as well as pharmaceuticals drugs for use as medication for patients to be administered or self-administered to cure them, alleviate or vaccinate them. Due to a rapid growth in chronic and infectious diseases, the global pharmaceutical market is growing at an exceptional rate leading to a rise in life expectancy of people all around the world. All the pharmaceuticals companies are governed by certain laws and regulations that govern the patenting, the testing, safety, efficiency and marketing of the drugs and medication the companies endorse or produce. To keep up with the rise in competitive market of pharmaceuticals, the leading players in the industry divert as much as around 10% of their turnover profits to their research departments. At MIR, our analysts go through the rapid changing marketing scenarios in the pharmaceuticals industry to gain the latest knowledge and insights. This helps us create the best analytical reports in the markets helping us predict a much accurate forecasts in the upcoming years for the pharmaceuticals market.
Chondroitin Sulfate Market by Application (Dietary Supplements, Veterinary, Pharmaceutical and Cosmetics), and Source (Porcine and Bovine) - Global Analysis & Forecast 2019-2030
Chondroitin Sulfate Market Overview and Introduction
Global Chondroitin Sulfate Market is estimated to be over US$ 360.0 Million in 2018. It is anticipated to grow at a 3.0% CAGR from 2019 to 2030.
Chondroitin sulfate is a type of sulfated glycosaminoglycan (GAG), which comprises of alternating chains of two major sugars, namely glucuronic acid and N-acetylgalactosamine. This chemical is commercially manufactured from animal sources, such as cow, sw
Published :Sep 2019 | Pages : 200 | Price starts from : $5100
Halal Nutraceuticals and Vaccines Market by Type (Halal Dietary Nutraceuticals, Halal Vaccines), Application (Sports Nutrition, General Well-Being, Immune & Digestive Health, Bone & Joint Health, Heart Health, Weight Loss) - Global Analysis & Forecast 2019-2030
Halal Nutraceuticals and Vaccines Market Overview and Introduction
Global Halal Nutraceuticals and Vaccines Market is estimated to be over US$ 40.0 Billion in 2018. It is anticipated to grow at a 7.8% CAGR from 2019 to 2030.
Halal nutraceuticals provide high nutritional value and health benefits and they are derived from halal food sources. They can be classified into dietary supplements and processed foods. Halal vaccines are non-toxic and do not contai
Published :Aug 2019 | Pages : 230 | Price starts from : $5100
Hemophilia Treatment Market by Type (Hemophilia A, Hemophilia B), Treatment (Replacement Therapy, ITI Therapy, Gene Therapy), Therapy (Demand, Prophylaxis) - Analysis & Forecast 2019-2026
Hemophilia Treatment Market Overview and Introduction
Global hemophilia treatment market is estimated to be over US$ 11.2 Bn in 2018. It is anticipated to grow at 5.7% CAGR from 2019 to 2026.
Hemophilia is an inherited bleeding disorder in which the blood does not clot properly which leads to prolonged bleeding or oozing following an injury or surgery. There are several types of hemophilia amongst which hemophilia A and hemophilia B are the most co
Published :Aug 2019 | Pages : 210 | Price starts from : $5100
Vaccines Market by Technology (Conjugate Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Inactivated and Subunit Vaccines and Recombinant Vaccines), Type (Monovalent Vaccines and Multivalent Vaccines), Disease Indication (Pneumococcal Disease, Influenza, Meningococcal Disease, Rotavirus, MMR, Dengue, DTP, HPV, Polio, Hepatitis, Varicella and Herpes Zoster), Route of Administration (Oral Administration, Intramuscular and Subcutaneous Administration) and Patient Type (Pediatric Patients, Adult Patients) – Analysis & Forecast 2019-2030
Vaccines Market Overview and Introduction
Vaccines market was estimated to be over US$ 30.0 Bn in 2018 and is anticipated to grow at a CAGR of 6.0% from 2019 to 2030.
Vaccines are biological preparations which are used to boost immunity by activating acquired immunity against a particular disease. Vaccines typically constitutes of agents resembling a disease-causing microorganism. It is fabricated from either a weakened or killed form of the microbe
Published :May 2019 | Pages : 150 | Price starts from : $5100
Biosimilars Market by Product (Recombinant Glycosylated Proteins (Monoclonal Antibodies (Rituximab, Adalimumab, and Infliximab), Erythropoietin, and Follitropin), Recombinant Non-Glycosylated Proteins (Insulin, Granulocyte Colony Stimulating Factor, Recombinant Human Growth Hormone and Interferon (Interferon-Alpha and Interferon-Beta)), Recombinant Peptides (Glucagon and Calcitonin)), Type of Manufacturing (In-house Manufacturing, and Contract Manufacturing), Disease (Chronic Disease , Oncology, Autoimmune Disease, Blood disorders, Infectious Diseases, and Growth Hormone Deficiency) - Global Forecast to 2030
Biosimilars Market Overview and Introduction
The global Biosimilars market was estimated to be over US$ 4,500 Mn in 2018. It is anticipated to grow at a CAGR of 31.4% from 2019 to 2030.
Biosimilars are bio-medical products that are identical copies of an original pharmaceutical drug, which has been manufactured by a different manufacturing company. Biosimilars are manufactured once the patent of the original product expires. Unlike generic drugs, b
Published :Apr 2019 | Pages : 150 | Price starts from : $5100
Alzheimer’s Drugs Market by Drug Class (Cholinesterase Inhibitors (Donepezil, Galantamine, Rivastigmine), NMDA Receptor Antagonists (Memantine)), by Distribution Channel (Direct Distribution Channel, Indirect Distribution Channel) - Analysis & Forecast 2019-2030
Alzheimer’s Drugs Market Overview and Introduction
Global Alzheimer’s Drugs Market is estimated to be over US$ 3.5 Billion in 2018. It is anticipated to grow at a 7.2% CAGR from 2019 to 2030.
Alzheimer’s disease is a progressive brain disorder, in which the brain gradually degenerates resulting in loss of memory, brain dysfunction, and cellular loss. It most often occurs in people aged above 65–70 years. A person afflicted wi
Published :Apr 2019 | Pages : 150 | Price starts from : $5100